Lerez 10mg Tablet
By Lerez
Rx
10 Tablet in a Strip

Composition
Lercanidipine(10mg)

Manufacturer - Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Limited, B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026.

Expires on or after
October, 2025

liver
When using Lerez 10mg Tablet, it is important to be cautious if you have liver disease. In such cases, your doctor may need to adjust the dosage of the medication. It is recommended to consult with your doctor before taking Lerez 10mg Tablet if you have any liver issues. However, if you have severe liver disease, it is not advised to use Lerez 10mg Tablet. Always seek guidance from your healthcare provider to ensure the safe use of this medication in relation to your liver health.

kidney
Caution Lerez 10mg Tablet requires caution in kidney disease patients. Dosage adjustment may be necessary. Avoid in severe kidney disease. Always seek doctor's advice.

alcohol
Caution is advised when consuming alcohol with Lerez 10mg Tablet. Consult your doctor regarding alcohol intake.

driving
Do not drive if you experience dizziness or weakness due to low blood pressure while taking Lerez 10mg Tablet.

pregnancy
Lerez 10mg Tablet may not be safe during pregnancy. Animal studies show potential harm to the baby, but human data is limited. Consult your doctor as they will assess the risks and benefits before prescribing.

breastfeeding
Lerez 10mg Tablet is likely unsafe during breastfeeding. Limited data shows it may pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | Dihydropyridine derivatives |
Therapeutic Class | CARDIAC |
Action Class | Calcium channel blockers- Dihydropyridines (DHP) |
₹35
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025